Cyanotech (OTCMKTS:CYAN) Issues Earnings Results

Cyanotech (OTCMKTS:CYAN) announced its earnings results on Monday. The biotechnology company reported $999.00 earnings per share for the quarter, Zacks reports. Cyanotech had a negative return on equity of 21.74% and a negative net margin of 7.14%.

Cyanotech Price Performance

Shares of OTCMKTS CYAN opened at $0.43 on Wednesday. The stock has a market cap of $3.21 million, a P/E ratio of -1.74 and a beta of 0.15. The firm’s 50-day simple moving average is $0.44 and its 200 day simple moving average is $0.41. Cyanotech has a fifty-two week low of $0.21 and a fifty-two week high of $0.57. The company has a quick ratio of 0.29, a current ratio of 1.01 and a debt-to-equity ratio of 0.13.

About Cyanotech

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body’s natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids.